Cite

HARVARD Citation

    Cremolini, C. et al. (n.d.). LBA-007Updated results of TRIBE2, a phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable mCRC. Annals of oncology. p. . [Online]. 
  
Back to record